EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mast cells act as pro-angiogenic and pro-tumorigenic players in pituitary gonadotroph tumors

Mirela-Diana Ilie iD, Álvaro Flores-Martínez iD, Marie Chanal, Maxime Lepetit iD, Benoit Samson, Ayoub Lehiani, Alexandre Vasiljevic iD, Laura Chinezu, Emmanuel Jouanneau iD, David Bernard iD, Olivier Gandrillon iD, Franck Picard iD und 2 weitere

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noaf241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Mirela-Diana Ilie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center of Lyon, Inserm U1052, CNRS UMR5286, Lyon 1 University, Lyon, France. Hauptthemen laut MEDLINE: Mast Cells, Pituitary Neoplasms, Tumor Microenvironment, Neovascularization, Pathologic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds de dotation pour la Recherche et l’Innovation en Endocrinologie et Maladies Métaboliques/Société Française d’Endocrinologie, la Ligue contre le Cancer, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The tumor microenvironment (TME) represents a promising avenue to understand gonadotroph tumors and develop therapeutic tools. Here, we aimed to gain insight into the tumorigenesis mechanisms driven by the gonadotroph TME.

Methods

Single-cell and spatial-omics were combined with histological analysis. Mice engrafted with tumor cells were used for functional validation.

Results

Using single-cell and spatial transcriptomic data from gonadotroph tumors and normal tissues, we identified mast cells in the microenvironment of gonadotroph tumors and confirmed their physical and functional interaction with endothelial cells. Quantification of mast cells in 40 patients suggested their pro-tumoral role as tumors relapsing after surgery harbored more mast cells. More interestingly, the distribution of mast cells was associated with the presence of a higher number of blood vessels, with an increased microvessel density (MVD), and with blood vessels with thicker walls. Ligand-receptor network analysis highlighted VEGFA as a modulator of mast/endothelial cell communication, a result confirmed by the identification of intratumoral mast cells expressing VEGFA in mouse and human gonadotroph tumors. Finally, using mice engrafted with gonadotroph tumor cells, we demonstrated that the depletion of mast cells reduces tumor volume through increased apoptosis. These observations were associated with increased hemorrhagic areas and a significant reduction of the number of blood vessels and MVD as evidenced in human gonadotroph tumors.

Conclusion

We demonstrate that mast cells represent a new actor of the gonadotroph TME, and highlight their pro-angiogenic and pro-tumorigenic roles as potential targets for the therapeutic treatment of gonadotroph tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsPituitary NeoplasmsTumor MicroenvironmentNeovascularization, PathologicAnimalsHumansMiceFemaleMaleTumor Cells, CulturedAdultMiddle AgedVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

gonadotroph adenomasmast cellssingle-cell transcriptomicsspatial transcriptomics| tumor microenvironment

Substanzen

Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Cancer Research Center of Lyon, Inserm U1052, CNRS UMR5286, Lyon 1 University, Lyon, France.
  • Endocrinology Department, "C.I.Parhon" National Institute of Endocrinology, Bucharest, Romania.
  • Laboratory of Biology and Modelling of the Cell, CNRS UMR 5239, ENS de Lyon, Lyon, France.
  • Neurosurgery Department, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France.
  • Pathology Department, Reference Center for Rare Pituitary Diseases HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France.
  • Department of Histology, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, Targu Mures, Romania.

ORCID-Profile: Mirela-Diana Ilie, Álvaro Flores-Martínez, Maxime Lepetit, Alexandre Vasiljevic, Emmanuel Jouanneau, David Bernard, Olivier Gandrillon, Franck Picard, Gérald Raverot, Philippe Bertolino

Förderung

  • Fonds de dotation pour la Recherche et l’Innovation en Endocrinologie et Maladies Métaboliques/Société Française d’Endocrinologie
  • la Ligue contre le Cancer
  • Agence Nationale de la Recherche
  • Fondation ARC pour la recherche sur le cancer

Zitieren

APA

Ilie, M. D., Flores-Martínez, Á., Chanal, M., Lepetit, M., Samson, B., Lehiani, A., Vasiljevic, A., Chinezu, L., Jouanneau, E., Bernard, D., Gandrillon, O., Picard, F., Raverot, G., & Bertolino, P. (2026). Mast cells act as pro-angiogenic and pro-tumorigenic players in pituitary gonadotroph tumors. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf241

Vancouver

Ilie MD, Flores-Martínez Á, Chanal M, Lepetit M, Samson B, Lehiani A, et al. Mast cells act as pro-angiogenic and pro-tumorigenic players in pituitary gonadotroph tumors. Neuro-Oncology. 2026. doi:10.1093/neuonc/noaf241

BibTeX
@article{Ilie2026,
  author = {Ilie, Mirela-Diana and Flores-Martínez, Álvaro and Chanal, Marie and Lepetit, Maxime and Samson, Benoit and Lehiani, Ayoub and Vasiljevic, Alexandre and Chinezu, Laura and Jouanneau, Emmanuel and Bernard, David and Gandrillon, Olivier and Picard, Franck and Raverot, Gérald and Bertolino, Philippe},
  title = {Mast cells act as pro-angiogenic and pro-tumorigenic players in pituitary gonadotroph tumors},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noaf241}
}
Kostenlos starten →